[go: up one dir, main page]

ES2186866T3 - Derivados de factores del antibiotico ge2270. - Google Patents

Derivados de factores del antibiotico ge2270.

Info

Publication number
ES2186866T3
ES2186866T3 ES97903258T ES97903258T ES2186866T3 ES 2186866 T3 ES2186866 T3 ES 2186866T3 ES 97903258 T ES97903258 T ES 97903258T ES 97903258 T ES97903258 T ES 97903258T ES 2186866 T3 ES2186866 T3 ES 2186866T3
Authority
ES
Spain
Prior art keywords
derivatives
unit
formula
pirrolidinilo
aminocarbonil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97903258T
Other languages
English (en)
Inventor
Sergio Lociuro
Paolo Tavecchia
Romeo Ciabatti
Ermenegildo Restelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biosearch Italia SpA
Original Assignee
Biosearch Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosearch Italia SpA filed Critical Biosearch Italia SpA
Application granted granted Critical
Publication of ES2186866T3 publication Critical patent/ES2186866T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)

Abstract

DERIVADOS MONO - O DI - SUSTITUIDOS DE LOS FACTORES C SUB,2A , D 2 Y E DE GE2270 DE LA FORMULA GENERAL (I), EN LA QUE W REPRESENTA UNA UNIDAD DE LA FORMULA (A), (B) O (C), R SUP,1 Y R 2 REPRESENTAN UNA VARIEDAD DE SUSTITUYENTES, X S UP,1 ES METILO, X 2 ES UNA UNIDAD - CH 2 - W 1 Y X 3 ES METILAMINO O AMINO, O X 1 ES UNA UNIDAD - CH 2 W 1 , X 2 ES METOXIMETILENO Y X 3 ES ME TILAMINO, CON LA CONDICION DE QUE CUANDO X 3 SEA AMINO, W SEA 2 (AMINOCARBONIL) - PIRROLIDINILO; Y CON LA CONDICION ADEMAS DE QUE CUANDO W SEA 2 - (AMINOCARBONIL) - PIRROLIDINILO, W SUP,1 NO SEA HIDROXI; Y LAS SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS. LOS DERIVADOS MONO - O DI - SUSTITUIDOS DEL ANTIBIOTICO GE2270 DE LA FORMULA (I) SON AGENTES ANTIMICROBIANOS ACTIVOS SOBRE TODO CONTRA LAS BACTERIAS GRAM POSITIVAS.
ES97903258T 1996-02-14 1997-02-12 Derivados de factores del antibiotico ge2270. Expired - Lifetime ES2186866T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96102145 1996-02-14

Publications (1)

Publication Number Publication Date
ES2186866T3 true ES2186866T3 (es) 2003-05-16

Family

ID=8222478

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97903258T Expired - Lifetime ES2186866T3 (es) 1996-02-14 1997-02-12 Derivados de factores del antibiotico ge2270.

Country Status (13)

Country Link
US (1) US6008225A (es)
EP (1) EP0880541B1 (es)
JP (1) JP2000505438A (es)
KR (1) KR19990082541A (es)
AT (1) ATE231163T1 (es)
AU (1) AU714958B2 (es)
CA (1) CA2242067A1 (es)
DE (1) DE69718442T2 (es)
DK (1) DK0880541T3 (es)
ES (1) ES2186866T3 (es)
HU (1) HUP9901007A3 (es)
IL (1) IL125107A (es)
WO (1) WO1997030078A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE121459T1 (de) * 1990-03-08 1995-05-15 Lepetit Spa Antibiotika ge 2270 faktoren b1, b2, c1, d1, d2, e und t.
US5882900A (en) * 1992-09-10 1999-03-16 Gruppo Lepetit S.P.A. Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium
DE69600244T2 (de) * 1995-02-07 1998-10-01 Biosearch Italia Spa Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
AU693989B2 (en) * 1995-02-07 1998-07-09 Vicuron Pharmaceuticals Inc. Basic oxazoline-amide derivatives of GE 2270 and GE 2270-like antibiotics
ATE509633T1 (de) * 2002-06-17 2011-06-15 Naicons S C A R L Verwendung eines amid-derivats des ge 2270 faktors a3 für die behandlung von akne
PT1565201T (pt) 2002-11-18 2019-02-05 Vicuron Pharmaceuticals Llc Métodos de administração de dalbavancina para o tratamento de infeções bacterianas
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
PE20080103A1 (es) * 2006-05-31 2008-04-03 Novartis Ag AMINOTIAZOLES COMO MODULADORES DEL FACTOR DE ELONGACION EF-Tu
EP2097423B1 (en) * 2006-12-20 2011-03-02 Novartis AG Aminothiazole macrocycles, their use as antibacterial compounds and processes for their production
WO2008148754A2 (en) 2007-06-04 2008-12-11 Novartis Ag Macrocycles and their uses
EA020205B1 (ru) 2007-12-12 2014-09-30 Новартис Аг Аминотиазолы, фармацевтические композиции на их основе и способы лечения бактериальной инфекции
WO2024136758A1 (en) * 2022-12-21 2024-06-27 Agency For Science, Technology And Research Thiopeptide compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202241A (en) * 1988-09-09 1993-04-13 Gruppo Lepetit S.P.A. Antibiotic GE 2270
DE69016284T2 (de) * 1989-07-04 1995-05-24 Lepetit Spa Antibiotikum GE 22270, Faktoren A1,A2,A3 und H.
ATE121459T1 (de) * 1990-03-08 1995-05-15 Lepetit Spa Antibiotika ge 2270 faktoren b1, b2, c1, d1, d2, e und t.
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
DE69224497T2 (de) * 1991-08-30 1998-07-02 Biosearch Italia Spa Faktor C2a des Antibiotikums CE 2270
KR100281661B1 (ko) * 1992-09-10 2001-02-15 클라우디오 쿼르타 항생물질 ge 2270 인자 a의 선택적 생산 증가 방법
AU3805295A (en) * 1994-11-08 1996-05-31 Gruppo Lepetit S.P.A. Microbial transformation process for obtaining antibiotic ge 2270 factor d2
AU693989B2 (en) * 1995-02-07 1998-07-09 Vicuron Pharmaceuticals Inc. Basic oxazoline-amide derivatives of GE 2270 and GE 2270-like antibiotics
DE69600244T2 (de) * 1995-02-07 1998-10-01 Biosearch Italia Spa Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika

Also Published As

Publication number Publication date
AU1768797A (en) 1997-09-02
ATE231163T1 (de) 2003-02-15
HUP9901007A2 (hu) 1999-07-28
WO1997030078A1 (en) 1997-08-21
JP2000505438A (ja) 2000-05-09
AU714958B2 (en) 2000-01-13
DK0880541T3 (da) 2003-05-05
US6008225A (en) 1999-12-28
DE69718442T2 (de) 2003-04-30
EP0880541B1 (en) 2003-01-15
CA2242067A1 (en) 1997-08-21
IL125107A0 (en) 1999-01-26
EP0880541A1 (en) 1998-12-02
DE69718442D1 (de) 2003-02-20
KR19990082541A (ko) 1999-11-25
HUP9901007A3 (en) 1999-11-29
IL125107A (en) 2002-12-01

Similar Documents

Publication Publication Date Title
ES2186866T3 (es) Derivados de factores del antibiotico ge2270.
TR199801282T2 (xx) Mutilin'in karbamoiloksi t�revleri ve antibakteriyel olarak kullan�m�.
SI0991407T1 (en) Stabilization of acid sensitive benzimidazols with amino/cyclodextrin combinations
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
EP0958836A3 (en) Contact lens disinfecting solution
ES2153836T3 (es) Composicion enmascaradora del sabor de agentes farmaceuticos amargos.
MX9307555A (es) Derivados de paclitaxel y formulaciones farmaceuticas que los contienen.
ES2061890T3 (es) Soluciones acuosas estabilizadas de 3-isotiazolinonas.
ES2156155T3 (es) Derivado de pirazol.
ES2186916T3 (es) Derivados de isoxazolina como agentes antimicrobianos.
DK0537418T3 (da) Hidtil ukendt bacillusbakterie og anvendelse heraf
CU23367A3 (es) Formulación de moxifloxacino con sal común
ES2171416T3 (es) Remedio contra la trombocitopenia.
HUP0000538A2 (hu) Eljárás készülékek fertőtlenítésére
ES2061419T1 (es) Derivados de benzofurano y su uso como estabilizadores contra las radiaciones uv.
ES2173197T3 (es) Una formula farmaceutica que contiene hormona de crecimiento e isoleucina.
ES2109993T3 (es) Derivados de 4-desoxi-4-epipodofilotoxina o sus sales farmaceuticamente aceptables.
ES2171555T3 (es) Formulacion farmaceutica que incluye una hormona de crecimiento y de valina.
AR014772A1 (es) Una formulacion acuosa que permite la estabilizacion de conjugados de peg-interferon alfa durante y despues de la liofilizacion, proceso para producir un polvo liofilizado, un polvo liofilizado, un proceso para producir una solucion de los conjudados peg-interferon-alfa y un articulo de manufactura
ES2173883T3 (es) Utilizacion de derivados de piperacina-acetamida contra los daños de reperfusion.
ES2056577T3 (es) Composicion biocida y uso.
ATE261425T1 (de) Erythromycin-derivate mit antibiotischer wirkung
ES2160834T3 (es) Derivado de fenil pirimidina opticamente activo como agente analgesico.
AU2001259801A1 (en) 3-methoxybenzyl thiourea derivatives and improved lipid compositions containing same
KR920009388A (ko) 니클로사미드를 함유하는 국소적용 침투방지 로션